These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16221700)

  • 1. Alpha-galactosidase activity should be examined in patients with proteinuria: what have we learned from a family affected with Fabry disease?
    Lee NC; Niu DM; Lin CY; Hsiao KJ; Yang AH; Ng YY
    Nephrol Dial Transplant; 2006 Feb; 21(2):549-50. PubMed ID: 16221700
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural history and treatment of renal involvement in Fabry disease.
    Branton M; Schiffmann R; Kopp JB
    J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S139-43. PubMed ID: 12068026
    [No Abstract]   [Full Text] [Related]  

  • 3. New mutation in female patient with renal variant of Fabry disease and HIV.
    Solis MA; Pascual B; Boscá M; Ramos V; Carda C; Monteagudo C; Torregrosa I; Pons S; Miguel A
    J Nephrol; 2010; 23(2):231-3. PubMed ID: 20155722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutation in the alpha-galactosidase A gene of atypical Fabry disease with only nephropathy.
    Sawada K; Mizoguchi K; Hishida A; Kaneko E; Koide Y; Nishimura K; Kimura M
    Clin Nephrol; 1996 May; 45(5):289-94. PubMed ID: 8738659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remarkable variability in renal disease in a large Slovenian family with Fabry disease.
    Verovnik F; Benko D; Vujkovac B; Linthorst GE
    Eur J Hum Genet; 2004 Aug; 12(8):678-81. PubMed ID: 15162124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephropathy in a case of Fabry's disease].
    Reyes Marín FA; Gómez Navarro B; Tamayo y Orozco J; Larriva Sahd J; Hernández Pando R; Velázquez Forero F; Peña JC
    Rev Invest Clin; 1991; 43(4):373-6. PubMed ID: 1665922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: a case report.
    Dziemianko I; Jezior D; Boratyńska M; Patrzałek D; Kuźniar J; Szyber P; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2925-7. PubMed ID: 18022018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical study of unusual cases of Fabry disease].
    Beĭer EM; Karpova EA; Udalova OV; Tsvetkova IV
    Vopr Med Khim; 1998; 44(5):494-500. PubMed ID: 9916266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
    Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
    Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
    Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
    Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiokeratomas in Fabry disease.
    Mutoh H; Konoshita T; Onoe T; Makino Y; Arakawa K; Nakamura H;
    Am J Med Sci; 2013 Oct; 346(4):302. PubMed ID: 22990047
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney involvement in Anderson-Fabry disease.
    Meroni M; Sessa A; Battini G; Tazzari S; Torri Tarelli L
    Contrib Nephrol; 1997; 122():178-84. PubMed ID: 9399062
    [No Abstract]   [Full Text] [Related]  

  • 13. Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome.
    Nance CS; Klein CJ; Banikazemi M; Dikman SH; Phelps RG; McArthur JC; Rodriguez M; Desnick RJ
    Arch Neurol; 2006 Mar; 63(3):453-7. PubMed ID: 16533976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemizygous Fabry disease associated with IgA nephropathy: a case report.
    Shimohata H; Yoh K; Takada K; Tanaka H; Usui J; Hirayama K; Kobayashi M; Yamagata K
    J Nephrol; 2009; 22(5):682-4. PubMed ID: 19810002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fabry's disease: kidney insufficiency in heterozygous patient].
    Pravatà G; Pinto G; Noto G; Aricò M
    G Ital Dermatol Venereol; 1989; 124(11-12):505-9. PubMed ID: 2561653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients.
    De Schoenmakere G; Poppe B; Wuyts B; Claes K; Cassiman D; Maes B; Verbeelen D; Vanholder R; Kuypers DR; Lameire N; De Paepe A; Terryn W
    Nephrol Dial Transplant; 2008 Dec; 23(12):4044-8. PubMed ID: 18596132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry nephropathy and the case for adjunctive renal therapy.
    Wanner C; Breunig F
    J Am Soc Nephrol; 2007 Sep; 18(9):2426-8. PubMed ID: 17699807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current management of Fabry disease].
    Cochat P; Liutkus A; Dubourg L; Levade T
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S167-71. PubMed ID: 17373218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
    Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
    Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
    Desnick RJ; Banikazemi M
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.